TheDaoIndex KDAO2011
4 years 10 months ago
Dr. K Costenbader #ACR21 #YearinReview add-ons Rx:
👉Avacopan for AAV: new oral C5a inh allowed for remission & prevention of relapse, aggressive pred taper https://t.co/39V3LLOYKZ
Eric Dein ericdeinmd
4 years 10 months ago
AURORA 1, Year in Review: Voclosporin as add-on therapy lupus nephritis. Approved in 1/2021 for active lupus nephritis, very positive data @rheumnow #ACR21 https://t.co/rudYD1OC59
Eric Dein ericdeinmd
4 years 10 months ago
Year in Review #ACR21. How do you feel about JAK inhibitor after one year of new studies and the new FDA warning? @Rheumnow
Janet Pope Janetbirdope
4 years 10 months ago
#ClinicalPearl #JAKi works in #ankylosingspondylitis (AS). Trial of #tofacitinib positive. Don’t confuse with jack ass! @YearinReview #ACR21 @RheumNow presented by Karen Costenbader https://t.co/2VvEMhiI8L
Eric Dein ericdeinmd
4 years 10 months ago
#ACR21 Year in Review: Stepped Exercise program for knee OA - decrease in pain and increase in function, without objective measures showing improvement. Time to prescribe exercise! @Rheumnow https://t.co/LrNZ3pBO9i
Bella Mehta bella_mehta
4 years 10 months ago
How to improve clinical care for knee OA? stepped exercise program helps WOMAC self reported pain outcomes in Knee OA Important RCT #ACR21 year in review by @karen_kc123 @RheumNow
@AnnalsofIM here is a paper https://t.co/RGIjBL9TuZ
Dr. John Cush RheumNow
4 years 10 months ago
#RheumPix https://t.co/gCcgE2QfIi
Cassandra Calabrese CCalabreseDO
4 years 10 months ago
Join us tomorrow at #ACR21 in the #COVID19 hub at 12p EST where I’ll be discussing outpatient management of high risk covid patients with @LCalabreseDO #mAbs @philipcrobinson @ACRheum https://t.co/LkSw48cnWw
Dr.Hala Fadhil , MD drhalafadhil
4 years 10 months ago
All respect to Dr.Alarcon
As she presents her path to rheumatology practice #ACR21 #rheumatology #RheumTwitter https://t.co/JKaeUEvqkx
LiSa ◡̈︎ rheumarhyme
4 years 10 months ago
#ACR21 Anti-IFN autoantibodies predisposing patients to severe COVID ...🤔 And can be done with quantiferon test! https://t.co/n3h4vpQGdR
Dr. Cush reviews the news, and kicks off ACR21 learning and how to take in the annual meeting.
Mysteries behind polyautoimmunity have confounded rheumatologists for decades. One such association, the co-existence of Familial Mediterranean Fever (FMF) and axial spondyloarthritis (axSpA), remains rare. In fact, we believe the rate to be between 0.5% and 7.5%. Two abstracts looking at axSpA and FMF were highlighted during ACR Convergence 2021.
Since the start of the pandemic, hydroxychloroquine (HCQ) was forced into the limelight for the prevention/treatment of COVID-19. When it was found to be ineffective for COVID-19 and might cause potential harm, the drug came under closer scrutiny for its safety profile.
Dr. John Cush RheumNow
4 years 10 months ago
RheumNow’s expanded coverage of the #ACR21 annual meeting is sponsored in part by @bmsnews, @JanssenUS, @Novartis. All content chosen by RheumNow & its Faculty.
Meral K. El Ramahi, MD MeralElRamahiMD
4 years 10 months ago
@DoctorYasmin concludes her wonderful, innovative keynote address by noting 2 things she would like to see change moving forward:
1. How we tend to the wellness of providers
2. Improving communication amongst medical colleagues & communication to the public.
#ACR21 @RheumNow https://t.co/BdyVgVr0on
